Catalyst Wire Dossier Catalyst Wire Dossier

REYATAZ

atazanavir · E.R. Squibb & Sons, L.L.C.
Drug timelines are a Plus or Pro feature.

93 regulatory and trial events tracked for REYATAZ, covering 2006-08-09 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada [Phase 2]

See pricing